Shri Ahimsa Naturals Limited (SHRIAHIMSA)
Latest quarterly results (H1 FY26)
In its latest reported quarter, H1 FY26, Shri Ahimsa's revenue was ₹61.0 Cr, and net profit ₹15.0 Cr; the operating margin was 29.5%.
| H1 FY26 (₹ Cr) | Value | YoY | vs prev. half |
|---|---|---|---|
| Revenue | ₹61.0 | — | — |
| Operating profit | ₹18.0 | — | — |
| Net profit | ₹15.0 | — | — |
| EPS (₹) | 6.36 | — | — |
| Operating margin | 29.5% | — | — |
SHRIAHIMSA delivery percentage
NSE end-of-day data for
On Fri, 23 Oct 2026, 64.0% of the SHRIAHIMSA shares traded on NSE were taken to delivery, against the stock's own 20-session average of 74.09%. That is close to its usual level. Turnover was only ₹60 lakh, so a handful of trades can move this figure.
Delivery in the last 5 sessions: 93.2% · 82.3% · 86.0% · 76.0% · 64.0%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Shri Ahimsa Naturals has approved the allotment of 7,10,400 equity shares of face value ₹10 each following the conversion of warrants issued on a preferential basis. The allotment was executed at an issue price of ₹227 per share (including a premium of ₹217) after receiving the remaining 75% consideration totaling ₹12.09 Cr from three public investors. Consequently, the company's paid-up equity share capital increases from 2,38,08,500 shares (₹23.81 Cr) to 2,45,18,900 shares (₹24.52 Cr). This follows an earlier tranche of 3,77,600 warrants converted in May 2026 out of the 13,34,400 warrants initially issued.
- Allotment of 7,10,400 equity shares at ₹227 per share (face value ₹10 + premium ₹217)
- Received ₹12,09,45,600 as the final 75% subscription amount from 3 public investors
- Paid-up share capital expanded from 2,38,08,500 shares to 2,45,18,900 shares
- Post-conversion holding of allottees (Poonam Rani, Raman Goyal, and Vimal Kishore Parwal HUF) stands at 2.90%
Shri Ahimsa Naturals Limited released the scrutinizer's report for its 36th Annual General Meeting held on September 14, 2026. A total of 26 members participated via remote e-voting, casting 1,64,62,200 votes, which represents 69.14% of the total paid-up share capital (2,38,08,500 shares). All three ordinary resolutions—adoption of FY26 financial statements, re-appointment of retiring director Mr. Nemi Chand Jain, and ratification of cost auditor remuneration for FY27—were approved unanimously with 100% votes in favor.
- Total voter turnout represented 69.14% of paid-up capital (1,64,62,200 out of 2,38,08,500 equity shares)
- Item 1: FY26 audited standalone and consolidated financial statements adopted with 100% assent (0 dissent)
- Item 2: Re-appointment of director Mr. Nemi Chand Jain approved with 100% assent
- Item 3: Ratification of Cost Auditors' remuneration for FY27 approved with 100% assent
- A total of 26 members participated in voting, with zero invalid votes recorded
Shri Ahimsa Naturals Limited concluded its 36th Annual General Meeting (AGM) on September 14, 2026. Shareholders considered three ordinary resolutions, including the adoption of FY2025-26 audited financial statements, the re-appointment of director Mr. Nemi Chand Jain, and ratification of cost auditors' remuneration for FY2026-27. Management highlighted strategic focus areas during the address, including ongoing capacity expansion via the Sawarda project and automation. Official scrutinizer voting results are expected within two working days.
- 36th Annual General Meeting held on September 14, 2026, at 02:30 PM IST and concluded at 3:00 PM IST
- Transacted 3 ordinary resolutions via remote e-voting and AGM e-voting
- Consolidated scrutinizer report and voting results to be declared within 2 working days
- Remote e-voting was conducted between September 11, 2026, and September 13, 2026
Shri Ahimsa Naturals Limited has scheduled an analyst and institutional investor interaction for Thursday, September 10, 2026, at 3:30 PM IST. The group interaction will take place virtually and is organized by Nuvama PCG. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting.
- Virtual group investor meeting scheduled for September 10, 2026, at 3:30 PM IST
- Session organized by Nuvama PCG for PMS, institutional, and individual investors
- Company confirmed no Unpublished Price Sensitive Information (UPSI) will be discussed
Shri Ahimsa Naturals Limited has issued the notice for its 36th Annual General Meeting scheduled for Monday, September 14, 2026, at 2:30 PM IST at its registered office in Jaipur. The agenda includes standard ordinary business such as the adoption of FY26 audited financial statements and director re-appointment. Special business includes ratifying the remuneration of Rs 30,000 for the cost auditor for FY27. Remote e-voting is scheduled from September 11, 2026, to September 13, 2026.
- 36th AGM scheduled for Monday, September 14, 2026 at 2:30 PM IST in Bagru, Jaipur
- Remote e-voting window open from September 11, 2026 (09:00 AM) to September 13, 2026 (05:00 PM)
- Book closure dates fixed from September 8, 2026 to September 14, 2026 (both days inclusive)
- Proposed remuneration of Rs 30,000 (excluding taxes/expenses) for Cost Auditor M/s Rajesh & Company for FY27
Financial Performance
Revenue Growth by Segment
Consolidated revenue from operations grew 22.7% YoY to INR 95.81 Cr (9,580.61 Lakhs) in FY 2024-25, primarily driven by higher volume growth of manufactured products in the caffeine processing segment.
Geographic Revenue Split
Shri Ahimsa is a primary exporter, supplying materials to more than 14 countries, which provides geographical diversification and reduces concentration risk in any single region.
Profitability Margins
Net Profit Margin stood at 22.86% in FY 2024-25, a slight decrease from 23.95% in FY 2023-24. Operating margins are expected to remain healthy at 25-30% over the medium term due to the company's ability to pass on cost increases in its niche segment.
EBITDA Margin
EBITDA Margin was 33.68% in FY 2024-25, compared to 35.17% in FY 2023-24, representing a YoY compression of 1.49 percentage points despite an absolute EBITDA growth of 17.5% to INR 32.27 Cr.
Capital Expenditure
The company has planned a capital expenditure of INR 35 Cr for its wholly-owned subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL), which is expected to become operational in fiscal 2027.
Credit Rating & Borrowing
The company's long-term bank facilities are rated 'Crisil BBB/Stable' (Reaffirmed May 2025). Borrowing costs are supported by a healthy interest coverage ratio of 34 times and low reliance on external funds.
Operational Drivers
Raw Materials
The primary raw materials are tea waste and crude caffeine (a by-product of coffee processing). Specific percentage of total cost for each is not disclosed, but they represent the bulk of operational inputs.
Import Sources
A large portion of the raw material requirement is imported from overseas markets to ensure adequate supply for servicing international orders.
Key Suppliers
Not disclosed in available documents, though the company maintains long-lasting relationships with multiple vendors to ensure uninterrupted flow of inventory.
Capacity Expansion
Current capacity is being scaled through strategic investments in subsidiary SAHPL, with an INR 35 Cr expansion project aimed at increasing installed capacity for core products by fiscal 2027.
Raw Material Costs
Raw material costs are a significant driver of the working capital-intensive operations; the company manages these through strategic sourcing and vendor diversification to mitigate price fluctuations.
Manufacturing Efficiency
Return on Capital Employed (ROCE) was healthy at 28% in fiscal 2025 and is projected to remain between 20-25% over the medium term, reflecting sound operating efficiency.
Strategic Growth
Expected Growth Rate
35%
Growth Strategy
Growth will be achieved by expanding manufacturing capacity via the INR 35 Cr SAHPL project, increasing global footprint in 14+ countries, and investing in R&D to improve process excellence and product quality.
Products & Services
The company processes and sells natural caffeine derived from tea waste and crude caffeine.
Brand Portfolio
Shri Ahimsa, Shri Ahimsa Naturals.
New Products/Services
The company is continuously adding new products to its portfolio to drive turnover above the INR 100 Cr mark in fiscal 2026.
Market Expansion
Plans involve further penetrating existing key markets while expanding into new geographies by building a strong local presence and acquiring new global customers.
External Factors
Industry Trends
The industry is characterized by a niche caffeine processing segment with a growing demand for natural ingredients; the company is positioning itself through technological improvements and capacity scaling.
Competitive Landscape
The company operates in a niche segment with high profitability, competing primarily on product quality and process technology.
Competitive Moat
The company's moat is built on the three-decade-long experience of its promoters and established relationships with overseas customers, which are sustainable due to high entry barriers in niche chemical processing.
Macro Economic Sensitivity
The company is sensitive to global economic slowdowns which could negatively impact export performance across its 14+ target countries.
Geopolitical Risks
Geopolitical tensions and trade disruptions are identified as key risks that may impact the company's ability to source crude caffeine and export finished products.
Regulatory & Governance
Industry Regulations
Operations are subject to international quality standards and certifications required for exporting caffeine products to premier global organizations.
Legal Contingencies
Pending matters include an advance payment of INR 21 Lakhs for agricultural land where the agreement is yet to be executed, and an insurance claim of INR 58.49 Lakhs lodged with United Insurance Company.
Risk Analysis
Key Uncertainties
Key uncertainties include the volatility of raw material prices and the successful commissioning of the SAHPL subsidiary's operations by fiscal 2027.
Geographic Concentration Risk
While exporting to 14+ countries, the company remains focused on international markets for the majority of its revenue growth.
Third Party Dependencies
There is a significant dependency on a limited number of crude caffeine suppliers, which the company is actively trying to mitigate by broadening its supplier network.
Technology Obsolescence Risk
The company faces risks from rapid technological advancements; it mitigates this by prioritizing technology investments and process innovations.
Credit & Counterparty Risk
Receivables quality is supported by established relationships with long-term customers in overseas markets.
